Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: Organization to assess strategies for ischemic syndromes (OASIS) pilot study results

Circulation

Volumn 98, Issue 11, 1998, Pages 1064-1070

  Anand, Sonia S ^a,b   Yusuf, Salim ^a   Pogue, Janice ^a   Weitz, Jeffrey I ^a   Flather, Marcus ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b McMaster Clinic   (Canada)

Author keywords

Angina; Ischemia; Thrombosis; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; HIRUDIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RESTENOSIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0032530662     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.11.1064     Document Type: Article

References (22)

1. Oler A, Whooley MA, Oler J, Grady D. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina: a meta-analysis. JAMA. 1996;276:811-815.
2. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med. 1992;327:141-145.
3. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 1994;308:81-106.
4. Yusuf S, Flather M, Pogue J, Hunt D, Varigos, Piegas, Avezum A, Keltai M, Budaj A, Ceremuzynski L. for the OASIS Registry Investigators. Risk of death, myocardial infarction and strokes in relationship to an invasive or conservative strategy in unstable angina or non-Q wave MI. Can J Cordiol. 1997;13(supplC):108C. Abstract.
5. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994;90:61-68.
6. Yusuf S, Flather M, Pogue J, Cook R, Schuld R, Campeau J, Morris A, Gill J, Joyner S, Sussex B, Marquis JF, Theroux P, Chan YK, Auger P, Johnston M, Johnston M, Jessel A, Anand S, Wietz J, for the OASIS Substudy. Contrasting clinical and biochemical evidence of reactivation of thrombosis following cessation of IV heparin or hirudin treatment in unstable angina. Can J Cardiol. 1996;96:164. Abstract.
7. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators. Comparison of the effects of 2 doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Circulation. 1997;96:769-777.
8. Pogue J, Marsh H, Flather M, Joyner C, Yusuf S. Is central adjudication necessary to avoid bias in clinical outcomes? Control Clin Trials. 1997; 18(suppl 3S):150S-151S. Abstract.
9. Coumadin Aspirin Reinfarction Study (CARS) Investigators. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet. 1997;350:389-396.
10. The Post-Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low density lipoprotein cholesterol levels and low dose anticoagulation on obstructive changes in saphenous-vein coronary artery bypass grafts. N Engl J Med. 1997;336:153-162.
11. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet. 1994;343:499-503.
12. Smith P, Arnesen H, Holme I. The effect of warfarin on mortality and reinfarction after myocardial infarction. N Engl J Med. 1990;323: 147-152.
13. Yusuf S, Michaelis W, Hua A, Turpie AGG, Garg R, Egan D, Lonn E, Hirsh J. Effects of oral anticoagulants on mortality, reinfarction and stroke after myocardial infarction. Circulation. 1995;92(suppl I):I-343. Abstract.
14. Ezekowitz MD, Bridgers SL, James KE, Carliner NH, Colling CL, Gornick CC, Krause-Steinrauf H, Kurtzke JF, Nazarian SM, Radford MJ, for the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992;327: 1406-1412.
15. Singer DE, Hughes RA, Gress DR, Sheehan MA, Oertel LB, Maraventano SW, Blewett DR, Rosner B, Kistler JP. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: the BAATAF study. Am Heart J. 1992;124:1567-1573.
16. Stroke prevention in atrial fibrillation study: final results. Circulation. 1991;84:527-539.
17. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin in high-risk patients with atrial fibrillation: stroke prevention in atrial fibrillation, III: randomized clinical trial. Lancet. 1996;348:633-638.
18. Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KA, Chesebro JH, Strain J, Keller C, Kelly A, Lancaster G, Ali J, Kronmal R, Fuster V, for the Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: primary end point analysis from the ATACS trial. Circulation. 1994;89: 81-88.
19. Williams M, Morison I, Parker J, Stewart R. Progression of the culprit lesion in unstable coronary artery disease with warfarin and aspirin versus aspirin alone: preliminary Study. J Am Coll Cardiol. 1997;30:364-369.
20. Roberts R, Rogers WJ, Mueller HS. Immediate versus differed beta-blockade following thrombolytic therapy in patients with acute MI: results of Thrombolysis in Myocardial Infarction (TIMI) II-B study. Circulation. 1991;83:422-437.
21. Braunwald E, for the TIMI-IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave MI: Results of the TIMI IIIB trial. Circulation. 1994;89:1545-1556.
22. Boden W, O'Rourke R, Crawford M, Blaustein A, Deedwania P, Zoble R, Wezler L, Kleiger R, Pepine C, Ferry D, Chow B, Lavori P, for the Veterans Affairs Non-Q-Wave Infarction Strategies (VANQWISH) Trial Investigators. N Engl J Med. 1998;338:1785-1792.